Nazneen Rahman has figured out a way to make genetic testing more easily accessible for UK women with ovarian cancer, writes Ed Yong at the Atlantic. Women with BRCA1 or BRCA2 mutations are more likely to respond to certain chemotherapy drugs and PARP inhibitors, but getting tested can be difficult.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.